

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 9.94741170 |
| 2 | regulation of cardioblast proliferation (GO:0003264) | 9.44461040 |
| 3 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 9.44461040 |
| 4 | cell migration involved in heart development (GO:0060973) | 9.36809174 |
| 5 | detection of temperature stimulus (GO:0016048) | 9.15839173 |
| 6 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 9.06205771 |
| 7 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 9.06205771 |
| 8 | ganglion development (GO:0061548) | 8.70307916 |
| 9 | dopaminergic neuron differentiation (GO:0071542) | 8.60453491 |
| 10 | behavioral response to nicotine (GO:0035095) | 8.23155179 |
| 11 | peripheral nervous system neuron development (GO:0048935) | 8.05645380 |
| 12 | coronary vasculature morphogenesis (GO:0060977) | 7.85052983 |
| 13 | regulation of heart morphogenesis (GO:2000826) | 7.13781439 |
| 14 | cartilage morphogenesis (GO:0060536) | 6.91417388 |
| 15 | cell migration in hindbrain (GO:0021535) | 6.88648326 |
| 16 | endocardial cushion morphogenesis (GO:0003203) | 6.68704949 |
| 17 | cardiac ventricle formation (GO:0003211) | 6.42609343 |
| 18 | tongue development (GO:0043586) | 6.31277224 |
| 19 | cardiac chamber formation (GO:0003207) | 6.19517331 |
| 20 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 6.02029620 |
| 21 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 6.02029620 |
| 22 | neuronal action potential (GO:0019228) | 5.97947596 |
| 23 | regulation of respiratory gaseous exchange (GO:0043576) | 5.76191163 |
| 24 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.64934501 |
| 25 | mesenchyme morphogenesis (GO:0072132) | 5.49947973 |
| 26 | regulation of cell proliferation involved in heart morphogenesis (GO:2000136) | 5.39391239 |
| 27 | mesenchymal cell proliferation (GO:0010463) | 5.28572991 |
| 28 | nuclear pore complex assembly (GO:0051292) | 5.01605434 |
| 29 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 5.00216654 |
| 30 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.99398164 |
| 31 | establishment of mitochondrion localization (GO:0051654) | 4.97583007 |
| 32 | neural crest cell migration (GO:0001755) | 4.95864616 |
| 33 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 4.95275355 |
| 34 | negative regulation of cell cycle arrest (GO:0071157) | 4.95009640 |
| 35 | behavioral response to pain (GO:0048266) | 4.91960909 |
| 36 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 4.89560637 |
| 37 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 4.89560637 |
| 38 | negative regulation of microtubule polymerization (GO:0031115) | 4.89254799 |
| 39 | response to pain (GO:0048265) | 4.75013756 |
| 40 | membrane depolarization during action potential (GO:0086010) | 4.68642822 |
| 41 | mitochondrion transport along microtubule (GO:0047497) | 4.66357104 |
| 42 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 4.66357104 |
| 43 | suckling behavior (GO:0001967) | 4.64222148 |
| 44 | response to water (GO:0009415) | 4.63875251 |
| 45 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.54193815 |
| 46 | cellular response to nicotine (GO:0071316) | 4.50302264 |
| 47 | intermediate filament organization (GO:0045109) | 4.47546309 |
| 48 | proline transport (GO:0015824) | 4.43136964 |
| 49 | nuclear pore organization (GO:0006999) | 4.42166129 |
| 50 | urinary tract smooth muscle contraction (GO:0014848) | 4.38640285 |
| 51 | neuronal action potential propagation (GO:0019227) | 4.36540682 |
| 52 | * negative regulation of dendrite morphogenesis (GO:0050774) | 4.29574758 |
| 53 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.23726477 |
| 54 | negative regulation of mRNA metabolic process (GO:1903312) | 4.23087541 |
| 55 | negative regulation of DNA repair (GO:0045738) | 4.21474344 |
| 56 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.19481360 |
| 57 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 4.14253333 |
| 58 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 4.11184667 |
| 59 | neuron fate specification (GO:0048665) | 4.10188177 |
| 60 | plasma membrane repair (GO:0001778) | 4.05565351 |
| 61 | retinal ganglion cell axon guidance (GO:0031290) | 4.04204558 |
| 62 | axon development (GO:0061564) | 4.03059856 |
| 63 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.02006376 |
| 64 | axon cargo transport (GO:0008088) | 4.01716233 |
| 65 | potassium ion export (GO:0071435) | 4.01614632 |
| 66 | regulation of respiratory system process (GO:0044065) | 3.92528739 |
| 67 | cell communication involved in cardiac conduction (GO:0086065) | 3.88959937 |
| 68 | adult heart development (GO:0007512) | 3.84081846 |
| 69 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.84018719 |
| 70 | apoptotic process involved in morphogenesis (GO:0060561) | 3.83631160 |
| 71 | synaptic vesicle maturation (GO:0016188) | 3.79761701 |
| 72 | ectodermal placode formation (GO:0060788) | 3.78216428 |
| 73 | regulation of translational termination (GO:0006449) | 3.74169388 |
| 74 | intermediate filament-based process (GO:0045103) | 3.70980374 |
| 75 | pore complex assembly (GO:0046931) | 3.68944506 |
| 76 | intermediate filament cytoskeleton organization (GO:0045104) | 3.66823587 |
| 77 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.64892231 |
| 78 | regulation of platelet aggregation (GO:0090330) | 3.58193771 |
| 79 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.56359323 |
| 80 | innervation (GO:0060384) | 3.55354935 |
| 81 | DNA duplex unwinding (GO:0032508) | 3.53181096 |
| 82 | response to acidic pH (GO:0010447) | 3.49594261 |
| 83 | apoptotic process involved in development (GO:1902742) | 3.49535400 |
| 84 | body morphogenesis (GO:0010171) | 3.49349582 |
| 85 | viral mRNA export from host cell nucleus (GO:0046784) | 3.46126196 |
| 86 | membrane budding (GO:0006900) | 3.44421194 |
| 87 | organelle transport along microtubule (GO:0072384) | 3.43848710 |
| 88 | embryonic body morphogenesis (GO:0010172) | 3.42140491 |
| 89 | glutamate secretion (GO:0014047) | 3.39633366 |
| 90 | DNA geometric change (GO:0032392) | 3.38794655 |
| 91 | action potential (GO:0001508) | 3.38231925 |
| 92 | regulation of transcription regulatory region DNA binding (GO:2000677) | 3.37150984 |
| 93 | neuromuscular synaptic transmission (GO:0007274) | 3.35011474 |
| 94 | regulation of cell maturation (GO:1903429) | 3.32775140 |
| 95 | neural crest cell development (GO:0014032) | 3.32126006 |
| 96 | regulation of striated muscle cell apoptotic process (GO:0010662) | 3.31647713 |
| 97 | eyelid development in camera-type eye (GO:0061029) | 3.31259206 |
| 98 | embryonic digit morphogenesis (GO:0042733) | 3.31138719 |
| 99 | synaptic vesicle exocytosis (GO:0016079) | 3.30607714 |
| 100 | negative regulation of protein autophosphorylation (GO:0031953) | 3.30559528 |
| 101 | protein polyglutamylation (GO:0018095) | 3.29627333 |
| 102 | negative regulation of complement activation (GO:0045916) | 3.26260210 |
| 103 | DNA unwinding involved in DNA replication (GO:0006268) | 3.24463517 |
| 104 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.23367051 |
| 105 | neuromuscular process controlling posture (GO:0050884) | 3.23184089 |
| 106 | developmental programmed cell death (GO:0010623) | 3.20901029 |
| 107 | central nervous system neuron axonogenesis (GO:0021955) | 3.20577780 |
| 108 | synaptic transmission, cholinergic (GO:0007271) | 3.19511284 |
| 109 | adenosine metabolic process (GO:0046085) | 3.19215435 |
| 110 | positive regulation of cell cycle checkpoint (GO:1901978) | 3.17723201 |
| 111 | regulation of mRNA catabolic process (GO:0061013) | 3.17115866 |
| 112 | outflow tract septum morphogenesis (GO:0003148) | 3.16677478 |
| 113 | negative regulation of cell aging (GO:0090344) | 3.16415644 |
| 114 | sympathetic nervous system development (GO:0048485) | 3.14955855 |
| 115 | establishment of monopolar cell polarity (GO:0061162) | 3.14646750 |
| 116 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.14646750 |
| 117 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.13973593 |
| 118 | negative regulation of histone acetylation (GO:0035067) | 3.13898457 |
| 119 | regulation of G2/M transition of mitotic cell cycle (GO:0010389) | 3.13618444 |
| 120 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 3.13273989 |
| 121 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.12035236 |
| 122 | axon regeneration (GO:0031103) | 3.09327683 |
| 123 | cell differentiation in hindbrain (GO:0021533) | 3.09317112 |
| 124 | positive regulation of DNA binding (GO:0043388) | 3.09308541 |
| 125 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.08049344 |
| 126 | peristalsis (GO:0030432) | 3.07610577 |
| 127 | spliceosomal complex assembly (GO:0000245) | 3.06632470 |
| 128 | vesicle transport along microtubule (GO:0047496) | 3.05776073 |
| 129 | membrane repolarization (GO:0086009) | 3.04584043 |
| 130 | behavioral response to ethanol (GO:0048149) | 3.03726589 |
| 131 | sodium ion transmembrane transport (GO:0035725) | 3.02760525 |
| 132 | regulation of cell cycle G2/M phase transition (GO:1902749) | 3.02186437 |
| 133 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.00178189 |
| 134 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.99553793 |
| 135 | regulation of early endosome to late endosome transport (GO:2000641) | 2.99484862 |
| 136 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.99395411 |
| 137 | positive regulation of axon extension (GO:0045773) | 2.99300268 |
| 138 | cellular response to BMP stimulus (GO:0071773) | 2.97700114 |
| 139 | response to BMP (GO:0071772) | 2.97700114 |
| 140 | positive regulation of potassium ion transport (GO:0043268) | 2.97444044 |
| 141 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.96820900 |
| 142 | acrosome reaction (GO:0007340) | 2.91820090 |
| 143 | regulation of membrane depolarization (GO:0003254) | 2.91215995 |
| 144 | skeletal muscle organ development (GO:0060538) | 2.87647474 |
| 145 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.87338321 |
| 146 | response to ATP (GO:0033198) | 2.86679431 |
| 147 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.86537918 |
| 148 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.86012369 |
| 149 | spinal cord motor neuron differentiation (GO:0021522) | 2.85191524 |
| 150 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.84864560 |
| 151 | microtubule-based transport (GO:0010970) | 2.83356877 |
| 152 | negative regulation of osteoblast differentiation (GO:0045668) | 2.82922960 |
| 153 | mesenchymal cell development (GO:0014031) | 2.82776378 |
| 154 | positive regulation of axonogenesis (GO:0050772) | 2.82396979 |
| 155 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.81554258 |
| 156 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.81289268 |
| 157 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.80457576 |
| 158 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.79880286 |
| 159 | sister chromatid segregation (GO:0000819) | 2.79583196 |
| 160 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.76452144 |
| 161 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146) | 2.74930995 |
| 162 | positive regulation of cell size (GO:0045793) | 2.74627961 |
| 163 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.73618636 |
| 164 | mitotic sister chromatid segregation (GO:0000070) | 2.72743054 |
| 165 | cranial nerve development (GO:0021545) | 2.72729776 |
| 166 | cellular response to ATP (GO:0071318) | 2.72354015 |
| 167 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.72146928 |
| 168 | alanine transport (GO:0032328) | 2.71955114 |
| 169 | dosage compensation (GO:0007549) | 2.70111221 |
| 170 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.70078629 |
| 171 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.70045334 |
| 172 | positive regulation of muscle hypertrophy (GO:0014742) | 2.70045334 |
| 173 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 2.69993884 |
| 174 | outer ear morphogenesis (GO:0042473) | 2.69663104 |
| 175 | negative regulation of cation channel activity (GO:2001258) | 2.68437752 |
| 176 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.68122125 |
| 177 | anterograde axon cargo transport (GO:0008089) | 2.64903330 |
| 178 | regulation of histone phosphorylation (GO:0033127) | 2.63952930 |
| 179 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.57309814 |
| 180 | protein-DNA complex disassembly (GO:0032986) | 2.56681382 |
| 181 | nucleosome disassembly (GO:0006337) | 2.56681382 |
| 182 | regulation of organ formation (GO:0003156) | 2.56460233 |
| 183 | heart morphogenesis (GO:0003007) | 2.55447410 |
| 184 | regulation of centriole replication (GO:0046599) | 2.54466004 |
| 185 | DNA conformation change (GO:0071103) | 2.53400608 |
| 186 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 2.46412895 |
| 187 | DNA replication initiation (GO:0006270) | 2.43367288 |
| 188 | regulation of translational fidelity (GO:0006450) | 2.42232761 |
| 189 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.38367616 |
| 190 | * enteric nervous system development (GO:0048484) | 11.2288282 |
| 191 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 10.2206195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.90379911 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 5.19531826 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 5.18009252 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.26714902 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.77690055 |
| 6 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.42906511 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.32379700 |
| 8 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.03606301 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.02347522 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.96284292 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.92103643 |
| 12 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.75850683 |
| 13 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.72868613 |
| 14 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.68222913 |
| 15 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.67517891 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.60213278 |
| 17 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.56855262 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.46101689 |
| 19 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.37137513 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.30637877 |
| 21 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28017380 |
| 22 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.24400696 |
| 23 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.24400696 |
| 24 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23983193 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.20316611 |
| 26 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19571921 |
| 27 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13881215 |
| 28 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.09794957 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.04649251 |
| 30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04141164 |
| 31 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.03269848 |
| 32 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.00646287 |
| 33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.95496288 |
| 34 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.93145571 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.91709024 |
| 36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.91149138 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.87034463 |
| 38 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.85250169 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85059498 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83849504 |
| 41 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82240105 |
| 42 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.81757810 |
| 43 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.78257440 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75042432 |
| 45 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74719359 |
| 46 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.72258721 |
| 47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.71243920 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.68631239 |
| 49 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67772363 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.66641020 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.65391589 |
| 52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.64953564 |
| 53 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.64554695 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.63289736 |
| 55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.62621463 |
| 56 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.61612024 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.61059012 |
| 58 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.58375902 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57463103 |
| 60 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.55789166 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55593345 |
| 62 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55263741 |
| 63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.53948017 |
| 64 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.53067633 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.52203160 |
| 66 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.52115304 |
| 67 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.51897190 |
| 68 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.51663156 |
| 69 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.51568961 |
| 70 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50696108 |
| 71 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48329783 |
| 72 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.47535407 |
| 73 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47510114 |
| 74 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.46103706 |
| 75 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.44279129 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40973508 |
| 77 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.40810359 |
| 78 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.39833629 |
| 79 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35730694 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34975059 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.33373916 |
| 82 | MYC_22102868_ChIP-Seq_BL_Human | 1.32041713 |
| 83 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31827404 |
| 84 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.31697605 |
| 85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31104233 |
| 86 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.30579058 |
| 87 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.29759817 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29069335 |
| 89 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.29009564 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28740260 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.28172744 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.26734891 |
| 93 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22892909 |
| 94 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22565028 |
| 95 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.22370668 |
| 96 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22194221 |
| 97 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22011432 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20713305 |
| 99 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19233785 |
| 100 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18203576 |
| 101 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18114200 |
| 102 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.17580996 |
| 103 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17560944 |
| 104 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.17475778 |
| 105 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17422130 |
| 106 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15864681 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13624962 |
| 108 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13597521 |
| 109 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.13348451 |
| 110 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11927033 |
| 111 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.11482916 |
| 112 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10946677 |
| 113 | * CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.10733660 |
| 114 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.10294991 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09680883 |
| 116 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09632989 |
| 117 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.09495755 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08817614 |
| 119 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.06387970 |
| 120 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06036409 |
| 121 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05715895 |
| 122 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.02501064 |
| 123 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.02501064 |
| 124 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.02501064 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02446770 |
| 126 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01707787 |
| 127 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01687515 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01381803 |
| 129 | KLF4_19829295_ChIP-Seq_ESCs_Human | 1.00592900 |
| 130 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.00209063 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99798755 |
| 132 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99462969 |
| 133 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99335236 |
| 134 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.99125477 |
| 135 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99106174 |
| 136 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.99090381 |
| 137 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97995985 |
| 138 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97758357 |
| 139 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97294175 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97054744 |
| 141 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97044538 |
| 142 | SA1_27219007_Chip-Seq_Bcells_Human | 0.95611756 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95411099 |
| 144 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.95311178 |
| 145 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.95209757 |
| 146 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.94062526 |
| 147 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.94000267 |
| 148 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.93727885 |
| 149 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93521345 |
| 150 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93225482 |
| 151 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.91615758 |
| 152 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.91599896 |
| 153 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91339331 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90838178 |
| 155 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.90219731 |
| 156 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88945627 |
| 157 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.88651877 |
| 158 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88505234 |
| 159 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.87782112 |
| 160 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.87465016 |
| 161 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87346407 |
| 162 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.86852061 |
| 163 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.86643166 |
| 164 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.86543777 |
| 165 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.86357077 |
| 166 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.84378671 |
| 167 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.80618916 |
| 168 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.80089928 |
| 169 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.79051340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002638_abnormal_pupillary_reflex | 9.71853270 |
| 2 | MP0002735_abnormal_chemical_nociception | 8.14386669 |
| 3 | MP0001968_abnormal_touch/_nociception | 6.82260053 |
| 4 | MP0002736_abnormal_nociception_after | 6.24882916 |
| 5 | MP0004858_abnormal_nervous_system | 5.32043962 |
| 6 | MP0002733_abnormal_thermal_nociception | 4.80141623 |
| 7 | MP0004270_analgesia | 4.65558157 |
| 8 | MP0003567_abnormal_fetal_cardiomyocyte | 4.47716481 |
| 9 | MP0006276_abnormal_autonomic_nervous | 4.47404653 |
| 10 | MP0001986_abnormal_taste_sensitivity | 4.07766223 |
| 11 | MP0002822_catalepsy | 4.00206065 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 3.85831900 |
| 13 | MP0001970_abnormal_pain_threshold | 3.82935325 |
| 14 | MP0001348_abnormal_lacrimal_gland | 2.43835042 |
| 15 | MP0008961_abnormal_basal_metabolism | 2.23863798 |
| 16 | MP0002272_abnormal_nervous_system | 2.15351697 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.09690606 |
| 18 | * MP0002751_abnormal_autonomic_nervous | 2.04225697 |
| 19 | MP0006138_congestive_heart_failure | 2.03421495 |
| 20 | MP0002067_abnormal_sensory_capabilities | 2.03276298 |
| 21 | MP0005187_abnormal_penis_morphology | 1.98435400 |
| 22 | MP0003077_abnormal_cell_cycle | 1.98233186 |
| 23 | * MP0002184_abnormal_innervation | 1.95382590 |
| 24 | MP0002127_abnormal_cardiovascular_syste | 1.94452642 |
| 25 | MP0005197_abnormal_uvea_morphology | 1.91291426 |
| 26 | MP0003111_abnormal_nucleus_morphology | 1.85499083 |
| 27 | MP0000955_abnormal_spinal_cord | 1.79303447 |
| 28 | MP0003937_abnormal_limbs/digits/tail_de | 1.72286219 |
| 29 | MP0003329_amyloid_beta_deposits | 1.71424327 |
| 30 | MP0010094_abnormal_chromosome_stability | 1.68008120 |
| 31 | MP0009046_muscle_twitch | 1.61413597 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.60964028 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.60703503 |
| 34 | MP0008057_abnormal_DNA_replication | 1.59602071 |
| 35 | MP0003880_abnormal_central_pattern | 1.53971302 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.52157235 |
| 37 | MP0003635_abnormal_synaptic_transmissio | 1.50149763 |
| 38 | MP0005083_abnormal_biliary_tract | 1.44542942 |
| 39 | MP0002697_abnormal_eye_size | 1.43399177 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.42882809 |
| 41 | MP0008260_abnormal_autophagy | 1.38177381 |
| 42 | MP0008932_abnormal_embryonic_tissue | 1.35502730 |
| 43 | MP0001730_embryonic_growth_arrest | 1.34010057 |
| 44 | MP0000049_abnormal_middle_ear | 1.32168071 |
| 45 | MP0004147_increased_porphyrin_level | 1.31927801 |
| 46 | MP0003868_abnormal_feces_composition | 1.24291493 |
| 47 | MP0003115_abnormal_respiratory_system | 1.21734389 |
| 48 | MP0003935_abnormal_craniofacial_develop | 1.20570214 |
| 49 | MP0002064_seizures | 1.16873299 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.15646828 |
| 51 | MP0010307_abnormal_tumor_latency | 1.15105616 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.12592804 |
| 53 | MP0002063_abnormal_learning/memory/cond | 1.09475354 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.08756627 |
| 55 | MP0000538_abnormal_urinary_bladder | 1.07850654 |
| 56 | * MP0002882_abnormal_neuron_morphology | 1.06466749 |
| 57 | MP0009745_abnormal_behavioral_response | 1.05906749 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.04984227 |
| 59 | MP0000778_abnormal_nervous_system | 1.02606591 |
| 60 | MP0001340_abnormal_eyelid_morphology | 1.02587441 |
| 61 | MP0002572_abnormal_emotion/affect_behav | 0.99438304 |
| 62 | MP0001661_extended_life_span | 0.99283982 |
| 63 | MP0000751_myopathy | 0.99019917 |
| 64 | * MP0002085_abnormal_embryonic_tissue | 0.96389533 |
| 65 | MP0000604_amyloidosis | 0.95829850 |
| 66 | MP0000534_abnormal_ureter_morphology | 0.95786597 |
| 67 | MP0002229_neurodegeneration | 0.95069311 |
| 68 | MP0003861_abnormal_nervous_system | 0.93518989 |
| 69 | MP0003634_abnormal_glial_cell | 0.93264693 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 0.92603721 |
| 71 | MP0002752_abnormal_somatic_nervous | 0.92220759 |
| 72 | MP0001440_abnormal_grooming_behavior | 0.92218366 |
| 73 | MP0000537_abnormal_urethra_morphology | 0.91542338 |
| 74 | MP0002653_abnormal_ependyma_morphology | 0.90160955 |
| 75 | MP0004142_abnormal_muscle_tone | 0.89746771 |
| 76 | MP0008874_decreased_physiological_sensi | 0.89329324 |
| 77 | MP0000749_muscle_degeneration | 0.87794007 |
| 78 | MP0003633_abnormal_nervous_system | 0.87207686 |
| 79 | MP0005380_embryogenesis_phenotype | 0.87125970 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 0.87125970 |
| 81 | MP0002109_abnormal_limb_morphology | 0.86676379 |
| 82 | MP0005391_vision/eye_phenotype | 0.86536545 |
| 83 | MP0002092_abnormal_eye_morphology | 0.86344879 |
| 84 | * MP0002084_abnormal_developmental_patter | 0.86062148 |
| 85 | MP0008058_abnormal_DNA_repair | 0.85523501 |
| 86 | MP0000350_abnormal_cell_proliferation | 0.85373865 |
| 87 | MP0008007_abnormal_cellular_replicative | 0.84427557 |
| 88 | MP0005253_abnormal_eye_physiology | 0.83470519 |
| 89 | MP0003984_embryonic_growth_retardation | 0.83246424 |
| 90 | MP0000747_muscle_weakness | 0.83135273 |
| 91 | MP0000428_abnormal_craniofacial_morphol | 0.82969628 |
| 92 | MP0004197_abnormal_fetal_growth/weight/ | 0.82379768 |
| 93 | MP0002066_abnormal_motor_capabilities/c | 0.81748526 |
| 94 | MP0008569_lethality_at_weaning | 0.80998751 |
| 95 | MP0002166_altered_tumor_susceptibility | 0.80664533 |
| 96 | MP0002088_abnormal_embryonic_growth/wei | 0.80270838 |
| 97 | MP0001697_abnormal_embryo_size | 0.79503431 |
| 98 | MP0003632_abnormal_nervous_system | 0.76678301 |
| 99 | * MP0000477_abnormal_intestine_morphology | 0.76408954 |
| 100 | MP0000762_abnormal_tongue_morphology | 0.76345248 |
| 101 | MP0003045_fibrosis | 0.75966068 |
| 102 | MP0003385_abnormal_body_wall | 0.75904548 |
| 103 | * MP0002080_prenatal_lethality | 0.75704111 |
| 104 | MP0002116_abnormal_craniofacial_bone | 0.75273762 |
| 105 | MP0002909_abnormal_adrenal_gland | 0.74785905 |
| 106 | MP0010771_integument_phenotype | 0.74256922 |
| 107 | MP0002932_abnormal_joint_morphology | 0.74195006 |
| 108 | * MP0001270_distended_abdomen | 0.74085729 |
| 109 | MP0005386_behavior/neurological_phenoty | 0.74064711 |
| 110 | MP0004924_abnormal_behavior | 0.74064711 |
| 111 | MP0001299_abnormal_eye_distance/ | 0.73896256 |
| 112 | MP0002114_abnormal_axial_skeleton | 0.73753523 |
| 113 | MP0005193_abnormal_anterior_eye | 0.70347443 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.69725269 |
| 115 | MP0009250_abnormal_appendicular_skeleto | 0.69261506 |
| 116 | MP0000313_abnormal_cell_death | 0.67657427 |
| 117 | MP0003631_nervous_system_phenotype | 0.67290031 |
| 118 | MP0004233_abnormal_muscle_weight | 0.67056278 |
| 119 | MP0003755_abnormal_palate_morphology | 0.65779951 |
| 120 | MP0005423_abnormal_somatic_nervous | 0.64947491 |
| 121 | MP0002163_abnormal_gland_morphology | 0.64468547 |
| 122 | MP0004145_abnormal_muscle_electrophysio | 0.63402423 |
| 123 | MP0001984_abnormal_olfaction | 0.63396931 |
| 124 | MP0005369_muscle_phenotype | 0.62174708 |
| 125 | MP0002081_perinatal_lethality | 0.61992049 |
| 126 | MP0004883_abnormal_blood_vessel | 0.61874029 |
| 127 | MP0003948_abnormal_gas_homeostasis | 0.61562028 |
| 128 | MP0008872_abnormal_physiological_respon | 0.59842489 |
| 129 | MP0003448_altered_tumor_morphology | 0.59232848 |
| 130 | MP0005171_absent_coat_pigmentation | 0.58844141 |
| 131 | MP0005646_abnormal_pituitary_gland | 0.58686872 |
| 132 | MP0003172_abnormal_lysosome_physiology | 0.58660183 |
| 133 | MP0002106_abnormal_muscle_physiology | 0.57788210 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.57590967 |
| 135 | MP0002160_abnormal_reproductive_system | 0.57326849 |
| 136 | MP0009379_abnormal_foot_pigmentation | 0.56885177 |
| 137 | MP0000733_abnormal_muscle_development | 0.55609258 |
| 138 | * MP0010770_preweaning_lethality | 0.55364163 |
| 139 | * MP0002082_postnatal_lethality | 0.55364163 |
| 140 | MP0009697_abnormal_copulation | 0.54524114 |
| 141 | MP0002269_muscular_atrophy | 0.54015471 |
| 142 | MP0009278_abnormal_bone_marrow | 0.53105000 |
| 143 | * MP0010769_abnormal_survival | 0.52472572 |
| 144 | MP0001849_ear_inflammation | 0.52425877 |
| 145 | MP0002557_abnormal_social/conspecific_i | 0.52239512 |
| 146 | MP0003943_abnormal_hepatobiliary_system | 0.52123773 |
| 147 | MP0004085_abnormal_heartbeat | 0.51063590 |
| 148 | MP0000639_abnormal_adrenal_gland | 0.50803581 |
| 149 | MP0001963_abnormal_hearing_physiology | 0.49423857 |
| 150 | MP0000579_abnormal_nail_morphology | 0.49210225 |
| 151 | MP0000759_abnormal_skeletal_muscle | 0.48797745 |
| 152 | MP0001486_abnormal_startle_reflex | 0.47857594 |
| 153 | MP0004036_abnormal_muscle_relaxation | 0.47775918 |
| 154 | MP0002009_preneoplasia | 0.47553654 |
| 155 | MP0008775_abnormal_heart_ventricle | 0.47209858 |
| 156 | MP0001905_abnormal_dopamine_level | 0.45781462 |
| 157 | MP0002837_dystrophic_cardiac_calcinosis | 0.45477499 |
| 158 | MP0003283_abnormal_digestive_organ | 0.44459723 |
| 159 | MP0001943_abnormal_respiration | 0.43787296 |
| 160 | MP0003183_abnormal_peptide_metabolism | 0.43711633 |
| 161 | MP0010386_abnormal_urinary_bladder | 0.42147472 |
| 162 | MP0003942_abnormal_urinary_system | 0.41989734 |
| 163 | MP0003137_abnormal_impulse_conducting | 0.41786903 |
| 164 | MP0003806_abnormal_nucleotide_metabolis | 0.40791553 |
| 165 | MP0000920_abnormal_myelination | 0.39121890 |
| 166 | MP0002972_abnormal_cardiac_muscle | 0.38633151 |
| 167 | MP0003315_abnormal_perineum_morphology | 0.37983060 |
| 168 | MP0001664_abnormal_digestion | 0.37788897 |
| 169 | MP0003122_maternal_imprinting | 0.37338101 |
| 170 | MP0005623_abnormal_meninges_morphology | 0.36649246 |
| 171 | MP0000427_abnormal_hair_cycle | 0.33248684 |
| 172 | MP0001919_abnormal_reproductive_system | 0.32312149 |
| 173 | MP0005410_abnormal_fertilization | 0.31190225 |
| 174 | MP0003879_abnormal_hair_cell | 0.31152309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 9.75587349 |
| 2 | Myokymia (HP:0002411) | 6.89638131 |
| 3 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 6.63205042 |
| 4 | Action tremor (HP:0002345) | 5.71750201 |
| 5 | Dysautonomia (HP:0002459) | 5.60157910 |
| 6 | Breast hypoplasia (HP:0003187) | 5.53546230 |
| 7 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.48944620 |
| 8 | Esophageal atresia (HP:0002032) | 5.21193985 |
| 9 | Pheochromocytoma (HP:0002666) | 5.18953227 |
| 10 | Termporal pattern (HP:0011008) | 5.07130756 |
| 11 | Insidious onset (HP:0003587) | 5.07130756 |
| 12 | Impaired pain sensation (HP:0007328) | 4.79439416 |
| 13 | Abnormality of pain sensation (HP:0010832) | 4.79439416 |
| 14 | Neuroendocrine neoplasm (HP:0100634) | 4.73081980 |
| 15 | Foot dorsiflexor weakness (HP:0009027) | 4.38481314 |
| 16 | Intestinal atresia (HP:0011100) | 4.31735178 |
| 17 | Steppage gait (HP:0003376) | 4.24123312 |
| 18 | Abnormality of the 2nd finger (HP:0004100) | 4.23499339 |
| 19 | Hammertoe (HP:0001765) | 4.22702709 |
| 20 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 4.18743140 |
| 21 | Abnormality of the phalanges of the hallux (HP:0010057) | 4.12243111 |
| 22 | Abnormality of the foot musculature (HP:0001436) | 3.90183192 |
| 23 | Depressed nasal tip (HP:0000437) | 3.80945378 |
| 24 | Febrile seizures (HP:0002373) | 3.79896748 |
| 25 | Hypercortisolism (HP:0001578) | 3.77670662 |
| 26 | Hypothermia (HP:0002045) | 3.73051119 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.67008055 |
| 28 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 3.64758348 |
| 29 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.63931830 |
| 30 | Supernumerary spleens (HP:0009799) | 3.56829915 |
| 31 | Failure to thrive in infancy (HP:0001531) | 3.48628722 |
| 32 | Atonic seizures (HP:0010819) | 3.45185415 |
| 33 | Hypoplastic nipples (HP:0002557) | 3.43135156 |
| 34 | Autoamputation (HP:0001218) | 3.42176077 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 3.41059702 |
| 36 | Myotonia (HP:0002486) | 3.37432717 |
| 37 | Distal arthrogryposis (HP:0005684) | 3.29329967 |
| 38 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 3.28698705 |
| 39 | Distal sensory impairment (HP:0002936) | 3.28564599 |
| 40 | Turricephaly (HP:0000262) | 3.26343690 |
| 41 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.26185289 |
| 42 | Shawl scrotum (HP:0000049) | 3.24689899 |
| 43 | Areflexia of lower limbs (HP:0002522) | 3.19411944 |
| 44 | Onion bulb formation (HP:0003383) | 3.18809306 |
| 45 | Neuroepithelial neoplasm (HP:0030063) | 3.15092541 |
| 46 | Nervous tissue neoplasm (HP:0030060) | 3.15092541 |
| 47 | Neuroectodermal neoplasm (HP:0030061) | 3.15092541 |
| 48 | Malignant neoplasm of the central nervous system (HP:0100836) | 3.14812647 |
| 49 | Ankle clonus (HP:0011448) | 3.11357112 |
| 50 | Distal lower limb muscle weakness (HP:0009053) | 3.09167719 |
| 51 | Secondary amenorrhea (HP:0000869) | 3.04250187 |
| 52 | Decreased motor nerve conduction velocity (HP:0003431) | 3.03039016 |
| 53 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.02600900 |
| 54 | Orthostatic hypotension (HP:0001278) | 2.98456266 |
| 55 | Tubulointerstitial fibrosis (HP:0005576) | 2.98042588 |
| 56 | Partial duplication of the phalanx of hand (HP:0009999) | 2.97471786 |
| 57 | External ophthalmoplegia (HP:0000544) | 2.97429355 |
| 58 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.96928983 |
| 59 | Thyroid carcinoma (HP:0002890) | 2.93270576 |
| 60 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.89568021 |
| 61 | Gastrointestinal atresia (HP:0002589) | 2.86421233 |
| 62 | Focal seizures (HP:0007359) | 2.78548754 |
| 63 | Sandal gap (HP:0001852) | 2.77213606 |
| 64 | Abnormality of the corticospinal tract (HP:0002492) | 2.75865268 |
| 65 | Abnormality of the vocal cords (HP:0008777) | 2.73945242 |
| 66 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.73772686 |
| 67 | Long toe (HP:0010511) | 2.73001616 |
| 68 | Chromsome breakage (HP:0040012) | 2.72479280 |
| 69 | Midline defect of the nose (HP:0004122) | 2.69717570 |
| 70 | Delayed cranial suture closure (HP:0000270) | 2.68456007 |
| 71 | Submucous cleft hard palate (HP:0000176) | 2.64411832 |
| 72 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.64030494 |
| 73 | Hypoplasia of the brainstem (HP:0002365) | 2.62269290 |
| 74 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.62269290 |
| 75 | Type 2 muscle fiber atrophy (HP:0003554) | 2.57958028 |
| 76 | Hypoventilation (HP:0002791) | 2.57679812 |
| 77 | Urinary urgency (HP:0000012) | 2.56704221 |
| 78 | Hypotrichosis (HP:0001006) | 2.56568827 |
| 79 | Palpebral edema (HP:0100540) | 2.56154663 |
| 80 | Hypoproteinemia (HP:0003075) | 2.52731615 |
| 81 | Abnormality of the parietal bone (HP:0002696) | 2.52217941 |
| 82 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.46630563 |
| 83 | Progressive cerebellar ataxia (HP:0002073) | 2.44347948 |
| 84 | Spastic gait (HP:0002064) | 2.44016546 |
| 85 | Abnormality of the lower motor neuron (HP:0002366) | 2.42076547 |
| 86 | Arthropathy (HP:0003040) | 2.41616814 |
| 87 | Thoracolumbar scoliosis (HP:0002944) | 2.37281507 |
| 88 | Bradycardia (HP:0001662) | 2.36804515 |
| 89 | Limb dystonia (HP:0002451) | 2.34688928 |
| 90 | Chin dimple (HP:0010751) | 2.33134352 |
| 91 | Annular pancreas (HP:0001734) | 2.32541090 |
| 92 | Amblyopia (HP:0000646) | 2.29990508 |
| 93 | Muscle fiber atrophy (HP:0100295) | 2.29837855 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.29554850 |
| 95 | Bowel diverticulosis (HP:0005222) | 2.29311788 |
| 96 | Facial asymmetry (HP:0000324) | 2.27191203 |
| 97 | Hyperparathyroidism (HP:0000843) | 2.25718728 |
| 98 | Fasciculations (HP:0002380) | 2.25327388 |
| 99 | Patellar aplasia (HP:0006443) | 2.25302666 |
| 100 | Tubulointerstitial abnormality (HP:0001969) | 2.23473715 |
| 101 | Potter facies (HP:0002009) | 2.22207751 |
| 102 | Facial shape deformation (HP:0011334) | 2.22207751 |
| 103 | Short palpebral fissure (HP:0012745) | 2.20965715 |
| 104 | Ventricular fibrillation (HP:0001663) | 2.19831850 |
| 105 | Overlapping toe (HP:0001845) | 2.19153544 |
| 106 | Coronal craniosynostosis (HP:0004440) | 2.18550452 |
| 107 | Bicornuate uterus (HP:0000813) | 2.18201011 |
| 108 | Poor suck (HP:0002033) | 2.15781180 |
| 109 | Muscle stiffness (HP:0003552) | 2.14504888 |
| 110 | Abnormal sex determination (HP:0012244) | 2.13389833 |
| 111 | Sex reversal (HP:0012245) | 2.13389833 |
| 112 | Cerebral hemorrhage (HP:0001342) | 2.12054947 |
| 113 | Asplenia (HP:0001746) | 2.08312006 |
| 114 | Muscle fibrillation (HP:0010546) | 2.07506836 |
| 115 | Generalized hypotonia (HP:0001290) | 2.06742327 |
| 116 | Abnormality of the musculature of the hand (HP:0001421) | 2.05574704 |
| 117 | Keratoconus (HP:0000563) | 2.05140813 |
| 118 | Increased corneal curvature (HP:0100692) | 2.05140813 |
| 119 | Abnormality of the parathyroid morphology (HP:0011766) | 2.05088052 |
| 120 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.04886948 |
| 121 | Impaired proprioception (HP:0010831) | 2.04566809 |
| 122 | Delusions (HP:0000746) | 2.04209735 |
| 123 | Absence seizures (HP:0002121) | 2.04174004 |
| 124 | Focal motor seizures (HP:0011153) | 2.03264247 |
| 125 | Menstrual irregularities (HP:0000858) | 2.03225449 |
| 126 | Postural tremor (HP:0002174) | 2.03026000 |
| 127 | Abnormality of magnesium homeostasis (HP:0004921) | 2.02896075 |
| 128 | Peripheral demyelination (HP:0011096) | 2.01993123 |
| 129 | Mask-like facies (HP:0000298) | 2.01414392 |
| 130 | Neonatal hypoglycemia (HP:0001998) | 2.00707079 |
| 131 | Asymmetry of the thorax (HP:0001555) | 10.3245518 |
| 132 | Growth hormone excess (HP:0000845) | 1.98959302 |
| 133 | Wide anterior fontanel (HP:0000260) | 1.98310941 |
| 134 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.98023024 |
| 135 | Paraplegia (HP:0010550) | 1.95476302 |
| 136 | Truncal ataxia (HP:0002078) | 1.95045486 |
| 137 | Lower limb muscle weakness (HP:0007340) | 1.94728789 |
| 138 | Abnormality of intracranial pressure (HP:0012640) | 1.93207960 |
| 139 | Increased intracranial pressure (HP:0002516) | 1.93207960 |
| 140 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.92365329 |
| 141 | Hand muscle atrophy (HP:0009130) | 1.90857470 |
| 142 | Aplasia/Hypoplasia of the nipples (HP:0006709) | 1.88873672 |
| 143 | Hyperacusis (HP:0010780) | 1.88400248 |
| 144 | Ectopic kidney (HP:0000086) | 1.87580048 |
| 145 | Dialeptic seizures (HP:0011146) | 1.87569060 |
| 146 | Abnormality of the duodenum (HP:0002246) | 1.86691306 |
| 147 | Neonatal onset (HP:0003623) | 1.85040570 |
| 148 | Pes cavus (HP:0001761) | 1.84151531 |
| 149 | Buphthalmos (HP:0000557) | 1.83609007 |
| 150 | Renovascular hypertension (HP:0100817) | 1.82906124 |
| 151 | Increased CSF protein (HP:0002922) | 1.82809070 |
| 152 | Abnormal hemoglobin (HP:0011902) | 1.82672208 |
| 153 | Protruding ear (HP:0000411) | 1.82534151 |
| 154 | Down-sloping shoulders (HP:0200021) | 1.81098262 |
| 155 | Visual hallucinations (HP:0002367) | 1.80334036 |
| 156 | Neuroblastic tumors (HP:0004376) | 1.79879667 |
| 157 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.79879667 |
| 158 | Neuroblastoma (HP:0003006) | 1.79879667 |
| 159 | Primitive neuroectodermal tumor (HP:0030065) | 1.79879667 |
| 160 | Anosmia (HP:0000458) | 1.79030834 |
| 161 | Spastic paraplegia (HP:0001258) | 1.78587625 |
| 162 | Rapidly progressive (HP:0003678) | 1.77460271 |
| 163 | Disproportionate tall stature (HP:0001519) | 1.76870769 |
| 164 | Thick eyebrow (HP:0000574) | 1.76725476 |
| 165 | Exotropia (HP:0000577) | 1.76474564 |
| 166 | Abnormality of the aortic arch (HP:0012303) | 1.76127401 |
| 167 | Generalized tonic-clonic seizures (HP:0002069) | 1.75776082 |
| 168 | Prominent occiput (HP:0000269) | 1.74712682 |
| 169 | Brachycephaly (HP:0000248) | 1.72987773 |
| 170 | Abnormality of the 4th metacarpal (HP:0010012) | 1.72824755 |
| 171 | Renal dysplasia (HP:0000110) | 1.72607248 |
| 172 | Underdeveloped supraorbital ridges (HP:0009891) | 1.69913533 |
| 173 | Absent radius (HP:0003974) | 1.69553348 |
| 174 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.69458194 |
| 175 | Abnormality of the carotid arteries (HP:0005344) | 1.66860029 |
| 176 | Meckel diverticulum (HP:0002245) | 1.65797864 |
| 177 | Broad distal phalanx of finger (HP:0009836) | 1.62391817 |
| 178 | Decreased skull ossification (HP:0004331) | 1.61239310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K10 | 5.11659654 |
| 2 | NTRK1 | 5.00625650 |
| 3 | PLK4 | 4.04466050 |
| 4 | LMTK2 | 3.96399733 |
| 5 | SRPK1 | 3.67800868 |
| 6 | TLK1 | 3.66104481 |
| 7 | MATK | 3.58986560 |
| 8 | MAPKAPK3 | 3.44980368 |
| 9 | ZAK | 3.25760431 |
| 10 | MINK1 | 3.24930634 |
| 11 | MAP3K9 | 3.24139537 |
| 12 | LATS2 | 3.12169442 |
| 13 | NTRK3 | 3.09651300 |
| 14 | KSR2 | 2.95037085 |
| 15 | NME2 | 2.93671085 |
| 16 | INSRR | 2.88968581 |
| 17 | LIMK1 | 2.39627893 |
| 18 | PBK | 2.35350412 |
| 19 | ARAF | 2.26559294 |
| 20 | GRK5 | 2.23186536 |
| 21 | MAP3K2 | 2.01367612 |
| 22 | PHKG1 | 1.99189318 |
| 23 | PHKG2 | 1.99189318 |
| 24 | RET | 1.97916015 |
| 25 | AKT3 | 1.95708056 |
| 26 | ALK | 1.92433392 |
| 27 | CDC7 | 1.88862446 |
| 28 | EEF2K | 1.87394585 |
| 29 | MAP3K11 | 1.82107648 |
| 30 | RIPK4 | 1.78523175 |
| 31 | MAP3K12 | 1.77967725 |
| 32 | BUB1 | 1.70423867 |
| 33 | EPHA3 | 1.69508298 |
| 34 | PAK6 | 1.64543071 |
| 35 | MAP2K4 | 1.57705153 |
| 36 | DYRK1B | 1.57634263 |
| 37 | SCYL2 | 1.49324388 |
| 38 | MAP3K4 | 1.47877199 |
| 39 | PIM2 | 1.45090571 |
| 40 | TRIB3 | 1.44386210 |
| 41 | NME1 | 1.43479643 |
| 42 | FGFR2 | 1.43243032 |
| 43 | BRD4 | 1.43098471 |
| 44 | UHMK1 | 1.36939339 |
| 45 | WNK1 | 1.33973659 |
| 46 | MAP2K1 | 1.33415981 |
| 47 | NEK1 | 1.29189415 |
| 48 | FER | 1.26087708 |
| 49 | PINK1 | 1.25439661 |
| 50 | CDK8 | 1.19777066 |
| 51 | CDK12 | 1.19236154 |
| 52 | CDK4 | 1.19016214 |
| 53 | TTK | 1.17417394 |
| 54 | TYRO3 | 1.16828288 |
| 55 | RPS6KA2 | 1.13717255 |
| 56 | NTRK2 | 1.12237211 |
| 57 | CHEK2 | 1.11592572 |
| 58 | CDK6 | 1.09674322 |
| 59 | MAP2K7 | 1.07017006 |
| 60 | MTOR | 1.06779236 |
| 61 | MAP3K1 | 1.01516631 |
| 62 | ATR | 0.99460299 |
| 63 | MARK3 | 0.99177803 |
| 64 | CDK7 | 0.97529033 |
| 65 | YES1 | 0.96221723 |
| 66 | ADRBK1 | 0.95887251 |
| 67 | MAPK11 | 0.94736344 |
| 68 | STK39 | 0.94373111 |
| 69 | CASK | 0.88838498 |
| 70 | VRK1 | 0.87945927 |
| 71 | WNK4 | 0.87627692 |
| 72 | SMG1 | 0.86561945 |
| 73 | MKNK2 | 0.86191805 |
| 74 | SGK223 | 0.85277319 |
| 75 | SGK494 | 0.85277319 |
| 76 | MAPK13 | 0.85039325 |
| 77 | EIF2AK1 | 0.83925587 |
| 78 | CAMKK2 | 0.83652094 |
| 79 | DDR2 | 0.82262591 |
| 80 | MET | 0.81489862 |
| 81 | CDK14 | 0.78909547 |
| 82 | MAP2K2 | 0.77060153 |
| 83 | PRKG2 | 0.76509993 |
| 84 | SIK3 | 0.76055067 |
| 85 | CDK5 | 0.75886787 |
| 86 | RPS6KB2 | 0.74128862 |
| 87 | TSSK6 | 0.73953646 |
| 88 | MAP2K3 | 0.66226500 |
| 89 | PTK2 | 0.66083191 |
| 90 | ICK | 0.65925340 |
| 91 | BRSK1 | 0.65839266 |
| 92 | AURKB | 0.63940272 |
| 93 | RIPK1 | 0.63002642 |
| 94 | BMPR1B | 0.62186294 |
| 95 | CAMKK1 | 0.61897127 |
| 96 | PAK4 | 0.61306785 |
| 97 | PLK1 | 0.60522610 |
| 98 | CDK2 | 0.60359748 |
| 99 | SGK2 | 0.59019065 |
| 100 | MAPKAPK5 | 0.58904123 |
| 101 | PKN1 | 0.58622101 |
| 102 | MAPK15 | 0.57880215 |
| 103 | AKT2 | 0.57452926 |
| 104 | CHEK1 | 0.57294103 |
| 105 | AURKA | 0.56774085 |
| 106 | PDGFRB | 0.56771570 |
| 107 | BRAF | 0.55645387 |
| 108 | PRKCG | 0.54545598 |
| 109 | EPHB1 | 0.53901857 |
| 110 | CAMK2G | 0.53779644 |
| 111 | IRAK2 | 0.52853338 |
| 112 | ATM | 0.51264407 |
| 113 | RAF1 | 0.51066369 |
| 114 | DYRK2 | 0.50641413 |
| 115 | NEK9 | 0.50286014 |
| 116 | DAPK1 | 0.49443541 |
| 117 | NEK2 | 0.48464643 |
| 118 | FLT3 | 0.48386259 |
| 119 | STK4 | 0.47964171 |
| 120 | CSNK1G3 | 0.47315059 |
| 121 | MKNK1 | 0.46936279 |
| 122 | CDK18 | 0.46936169 |
| 123 | RPS6KL1 | 0.45796038 |
| 124 | RPS6KC1 | 0.45796038 |
| 125 | DAPK2 | 0.45503528 |
| 126 | TRPM7 | 0.44943715 |
| 127 | IRAK1 | 0.44825354 |
| 128 | PDGFRA | 0.44683929 |
| 129 | PDPK1 | 0.44310127 |
| 130 | CDK1 | 0.43918635 |
| 131 | CSNK1A1L | 0.43784710 |
| 132 | CDC42BPA | 0.42665463 |
| 133 | AKT1 | 0.42582397 |
| 134 | CDK15 | 0.42567661 |
| 135 | HIPK2 | 0.42451403 |
| 136 | CLK1 | 0.40370675 |
| 137 | CSNK1G1 | 0.40314981 |
| 138 | ADRBK2 | 0.40048524 |
| 139 | CSNK1G2 | 0.39020471 |
| 140 | RPS6KA5 | 0.38897670 |
| 141 | PRKCE | 0.38861900 |
| 142 | PAK3 | 0.38751927 |
| 143 | PRKCZ | 0.38544538 |
| 144 | PIM1 | 0.36977780 |
| 145 | PDK1 | 0.36616256 |
| 146 | CAMK2A | 0.36475278 |
| 147 | PKN2 | 0.36200071 |
| 148 | FGFR3 | 0.36119974 |
| 149 | SGK3 | 0.35994689 |
| 150 | CDK11A | 0.35430957 |
| 151 | CAMK4 | 0.33989227 |
| 152 | FGR | 0.33981227 |
| 153 | CDK3 | 0.33885059 |
| 154 | MAPK10 | 0.33212229 |
| 155 | MELK | 0.32569627 |
| 156 | RPS6KA6 | 0.32417536 |
| 157 | GRK7 | 0.32237107 |
| 158 | MAPK14 | 0.32179867 |
| 159 | CSNK1E | 0.31092860 |
| 160 | BLK | 0.31003789 |
| 161 | MAP2K6 | 0.30834329 |
| 162 | FGFR4 | 0.29935009 |
| 163 | ERBB2 | 0.29829254 |
| 164 | TAOK1 | 0.28336266 |
| 165 | PRKDC | 0.27349232 |
| 166 | PRKACG | 0.27217529 |
| 167 | MAP3K6 | 0.27003894 |
| 168 | PRKD3 | 0.26455658 |
| 169 | PRKACA | 0.25658171 |
| 170 | PRKAA1 | 0.24741274 |
| 171 | MAPK1 | 0.24254191 |
| 172 | CSNK2A2 | 0.24026816 |
| 173 | PRPF4B | 0.23983853 |
| 174 | PASK | 0.23572613 |
| 175 | PRKD2 | 0.21778013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.98265492 |
| 2 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.84712651 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.54510532 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.46342732 |
| 5 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 3.34559224 |
| 6 | Alcoholism_Homo sapiens_hsa05034 | 3.23133509 |
| 7 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.95895357 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.71759144 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.68875747 |
| 10 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.67481181 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.58302621 |
| 12 | Thyroid cancer_Homo sapiens_hsa05216 | 2.44496356 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.40474305 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.33550591 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.24763756 |
| 16 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 2.24083939 |
| 17 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.13660092 |
| 18 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.12021197 |
| 19 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.11083777 |
| 20 | Base excision repair_Homo sapiens_hsa03410 | 2.06744583 |
| 21 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.99723845 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.96099792 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.89886472 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.84296619 |
| 25 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.83490519 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68704872 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62406825 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.61492848 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.59397834 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.58479060 |
| 31 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.55464210 |
| 32 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.52285811 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51782507 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.48162107 |
| 35 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.46670294 |
| 36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.45110955 |
| 37 | Gap junction_Homo sapiens_hsa04540 | 1.44901766 |
| 38 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.41730559 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41606784 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.31685310 |
| 41 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.31097972 |
| 42 | Lysine degradation_Homo sapiens_hsa00310 | 1.29987324 |
| 43 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.28827447 |
| 44 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.26903047 |
| 45 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.25766248 |
| 46 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.23839674 |
| 47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.23727487 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22040233 |
| 49 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.21855062 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 1.20185876 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 1.20069846 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.19885021 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19638539 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.18231368 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17251689 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.16465221 |
| 57 | Long-term potentiation_Homo sapiens_hsa04720 | 1.15111910 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11457614 |
| 59 | Homologous recombination_Homo sapiens_hsa03440 | 1.09922952 |
| 60 | Glioma_Homo sapiens_hsa05214 | 1.08303059 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.06737571 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06657427 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 1.06178303 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.03517884 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.03227967 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.03224164 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00257200 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98635186 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.98592607 |
| 70 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98433350 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.98207713 |
| 72 | Endometrial cancer_Homo sapiens_hsa05213 | 0.96944070 |
| 73 | Melanoma_Homo sapiens_hsa05218 | 0.96378871 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.96253964 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.96215701 |
| 76 | Long-term depression_Homo sapiens_hsa04730 | 0.95409787 |
| 77 | Circadian entrainment_Homo sapiens_hsa04713 | 0.94946521 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.93262987 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.92637053 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.92446478 |
| 81 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92161114 |
| 82 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91104926 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89750757 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.87181372 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85644338 |
| 86 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84333408 |
| 87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.84162681 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84061415 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.83800745 |
| 90 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.83647314 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82997398 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81262172 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.80206719 |
| 94 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.79632245 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.78604521 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.77676814 |
| 97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77141388 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76382299 |
| 99 | Bile secretion_Homo sapiens_hsa04976 | 0.73412178 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71768963 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71669324 |
| 102 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71142915 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69866966 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.69280259 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.67889000 |
| 106 | Ribosome_Homo sapiens_hsa03010 | 0.67810515 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.67457682 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67426585 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67113577 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66688354 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.66472167 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66023911 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.65923558 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65717567 |
| 115 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.64529607 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.64472556 |
| 117 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64457803 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.62773163 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.62561995 |
| 120 | Proteasome_Homo sapiens_hsa03050 | 0.61867944 |
| 121 | Purine metabolism_Homo sapiens_hsa00230 | 0.61267084 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60719905 |
| 123 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60099024 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.59509084 |
| 125 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58568856 |
| 126 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58344696 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58165097 |
| 128 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57843438 |
| 129 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57758737 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57329176 |
| 131 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56730180 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56416540 |
| 133 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56234091 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55525598 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.55440231 |
| 136 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.55284478 |
| 137 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54741517 |
| 138 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54389294 |
| 139 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53905933 |
| 140 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53700932 |
| 141 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.53052275 |
| 142 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.53008870 |
| 143 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52354732 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.51701152 |
| 145 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50310240 |
| 146 | Huntingtons disease_Homo sapiens_hsa05016 | 0.50081896 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48793765 |
| 148 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48438943 |
| 149 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47942912 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.47855624 |
| 151 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47665315 |
| 152 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47167417 |
| 153 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46814617 |
| 154 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.46497015 |
| 155 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46022128 |
| 156 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45410787 |
| 157 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45311876 |
| 158 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44616694 |
| 159 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42343774 |
| 160 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41887760 |
| 161 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37913566 |
| 162 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37043105 |
| 163 | RNA degradation_Homo sapiens_hsa03018 | 0.33423748 |
| 164 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32084805 |
| 165 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.31666314 |
| 166 | Hepatitis B_Homo sapiens_hsa05161 | 0.30380059 |
| 167 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30355910 |
| 168 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29400336 |

